Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis

We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentiviral vectors are more efficient for lung gene transfer than non-viral vectors in preclinical models. In preparation for a first-in-man CF trial using the lentiviral vector, we have undertaken key translational preclinical studies. Regulatory-compliant vectors carrying a range of promoter/enhancer elements were assessed in mice and human air-liquid interface (ALI) cultures to select the lead candidate; cystic fibrosis transmembrane conductance receptor (CFTR) expression and function were assessed in CF models using this lead candidate vector. Toxicity was assessed and 'benchmarked' against the leading non-viral formulation recently used in a Phase IIb clinical trial. Integration site profiles were mapped and transduction efficiency determined to inform clinical trial dose-ranging. The impact of pre-existing and acquired immunity against the vector and vector stability in several clinically relevant delivery devices was assessed. A hybrid promoter hybrid cytosine guanine dinucleotide (CpG)- free CMV enhancer/elongation factor 1 alpha promoter (hCEF) consisting of the elongation factor 1α promoter and the cytomegalovirus enhancer was most efficacious in both murine lungs and human ALI cultures (both at least 2-log orders above background). The efficacy (at least 14% of airway cells transduced), toxicity and integration site profile supports further progression towards clinical trial and pre-existing and acquired immune responses do not interfere with vector efficacy. The lead rSIV.F/HN candidate expresses functional CFTR and the vector retains 90-100% transduction efficiency in clinically relevant delivery devices. The data support the progression of the F/HN-pseudotyped lentiviral vector into a first-in-man CF trial in 2017

Mott insulator state in a van der Waals flat-band compound

When many-body effects dominate over the kinetic energy of electrons, they will lead to exotic quantum phenomena, such as the fractional quantum Hall effect, unconventional superconductivity, Mott insulator, quantum spin liquid, ferromagnetism, heavy fermion behavior and so on. Flat-band systems, in which the kinetic energy is strongly quenched, are promising for realizing many-body quantum phases, such as the Mott-like insulator states and superconductivity associated with the flat bands emerging in twisted bilayer graphene. In this work, we have discovered a room-temperature Mott insulator state, which is derived from a half-filled flat band in a van der Waals compound Nb3Cl8. Since the half-filled flat band is well separated from the other bands, the Mott insulator state in Nb3Cl8 is a straightforward realization of the celebrated single-band Hubbard model. Our discovery provides an intriguing platform for studying the fundamental physics of Mott insulator, and paves the way for more correlated electronic states and Mott insulator-based devices by taking advantage of the high tunability of the electronic states of two-dimensional materials.Comment: 19 pages, 4 figure